Friday 6 November 2026
Export MD’s income statement to Excel — free account
Pediatrix Medical Group, Inc.
MD Healthcare Medical Care Facilities
Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.
- Revenue
- +1.72%
- EPS
- −27.6%
- Free cash flow
- −14.4%
- Total debt
- −4.11%
Quarter to September 2026, against a year earlier
31.73
1.07
−3.26%
Follow MD
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 8 | 7 | 7 |
| 20.28% | 20.89% | 20.39% | 17.25% | ||
| 7.52% | 8.57% | 8.26% | 6.92% | ||
ROIC |
13.55% | 11.97% | 12.69% | 13.27% | |
Return on Tangible Assets |
48.11% | 93.93% | 88.61% | 80.87% | |
Average Days of Receivables |
46.21 | 44.78 | 44.72 | 44.77 | |
Free Cash Flow per Share |
3.00 | 2.93 | 2.88 | 2.71 | |
Free Cash Flow |
252.63 | 237.32 | 228.61 | 209.59 | |
Capital Expenditures |
(18.46) | (21.39) | (18.25) | (17.29) | |
| Other line items | |||||
Cash ROIC |
12.87% | 13.20% | 12.23% | 11.31% | |
Accounts Receivable Turnover |
7.43 | 7.89 | 8.03 | 8.25 | |
Accounts Payable Turnover |
3.47 | 6.06 | 4.76 | 4.16 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
107.83 | 60.57 | 76.57 | 86.46 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.24) | (0.23) | (0.23) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.58% | 12.55% | 12.72% | 12.76% | |
Share Based Compensation of Revenue |
0.94% | 0.99% | 1.04% | 1.09% | |
Interest Coverage |
5.81 | 6.23 | 6.31 | 6.38 | |
Operating CF/Net income |
1.64 | 1.48 | 1.41 | 1.51 | |
Depreciation/Fixed assets |
0.58 | 0.57 | 0.61 | 0.65 | |
Capex/Depreciation |
(0.81) | (0.91) | (0.77) | (0.71) | |
Revenue per Share |
22.76 | 23.88 | 24.55 | 25.35 | |
Operating CF per Share |
3.22 | 3.20 | 3.11 | 2.94 | |
Capex per Share |
(0.22) | (0.26) | (0.23) | (0.22) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 2 Nov 2026